International Business Machines Corp. (NYSE:IBM) has established partnerships with Apple Inc. (NASDAQ:AAPL) and the world’s largest medical devices producers to deliver health data from Apple Watches to doctors and insurers. Another major goal is to craft personalized treatments for hip replacement patients and diabetics.
IBM’s foray into digital healthcare will empower users monitoring their heart beat rate, calories expended and cholesterol levels utilizing Apple’s HealthKit platform to upload the data from an IBM app to a storage cloud. The latter will be accessible to the user’s physicians and insurance firms. Those who go for Apple’s ResearchKit can share their information with medical researchers.
The alliance is one among the many instances of collaboration between the technology and healthcare sectors. The driving force is the widely expected medical data explosion sourced from smartphone or wearables such as the Apple Watch or Fitbit.
The fact is that IBM doesn’t have an exclusive alliance with Apple. However the Apple group opined that few companies could provide the iPhone developer the same level of security and storage capabilities. Apple perceives the data to be highly sensitive and is pretty satisfied with IBM’s track record for operating secure data centres.
Along with the announcement of the IBM-Apple collaboration, a couple of healthcare partnerships including with Medtronic and Johnson & Johnson were declared. The latter are the world’s leading makers of medical devices including replacement knees and hips; and insulin pumps.
J&J has requested IBM to come up with a so called coaching system. The latter would make sure patients are ready health wise to undergo joint replacement or spinal surgery. Also it would motivate them to practice the right exercises post operation. If the subject was found wanting in any aspect the system would encourage him to rectify the shortcoming.
International Business Machines Corp. (NYSE:IBM) is collaborating with Medtronic on an intelligent diabetes treatment system that would source readings from a patient’s glucose monitor to make sure their insulin pump dispenses the exact amount of drug needed.